Y0002407

Brivaracetam CRS

European Pharmacopoeia (EP) Reference Standard

• Sinônimo(s): Brivaracetam, (αS,4R)-α-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide, (2S)-2-[(4R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide, (S)-2-((R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide, UCB 34714, UCB-34714, UCB34714
• Fórmula empírica (Notação de Hill): C₁₁H₂₀N₂O₂
• Número CAS: 357336-20-0
• Peso molecular: 212.29
• Número MDL: MFCD25976668
• Código UNSPSC: 41116107
• Código UNSPSC: 12352200
• NACRES: NA.24

Propriedades

• grau: pharmaceutical primary standard
• fabricante/nome comercial: EDQM
• aplicação(ões): pharmaceutical
• temperatura de armazenamento: 2-8°C

Descrição

Descrição geral

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. Compendial materials should be used for the purpose described in the appropriate monograph unless otherwise authorized by the National Competent Authority. For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicação

e.g. pharmaceutical (small molecule)

Ações bioquímicas/fisiológicas

Brivaracetam shows approximately 10 times greater potency than levetiracetam (Keppra)*; pIC50 at LBS = 7.0; inhibits audiogenic seizures in seizure-prone mice (ED50 = 14 μmol/kg) and is also effective in other animal models of epilepsy. Brivaracetam is used as an anticonvulsant (antiepileptic) for seizure treatment.

Embalagem

Unit quantity: 160mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit EDQM reference substance catalogue.

Outras notas

Sales restrictions may apply.

Informações de segurança

• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 3
• Ponto de fulgor (°F): Not applicable
• Ponto de fulgor (°C): Not applicable